Literature DB >> 1445973

Impaired activity of natural killer cells in patients with acute brucellosis.

I Salmerón1, M Rodríguez-Zapata, O Salmerón, L Manzano, S Vaquer, M Alvarez-Mon.   

Abstract

Researchers have claimed that natural killer (NK) cells are involved in the mechanisms of defense of the host against infections. We have investigated the activity of NK cells in peripheral blood mononuclear cells (PBMNC) from 12 patients for whom acute brucellar infection has been diagnosed and from 14 healthy controls. The sera of eight of the patients were also analyzed 3 months after initiation of a 45-day course of antibiotic treatment, at which time they had no evidence of relapse. PBMNC from patients with acute brucellar infection showed a significantly depressed NK cell activity (P < .01) when compared with those from healthy controls; this depressed activity was not related to a deficient number of NK cells since the numbers of CD56+ and CD16+ cells present in PBMNC were similar in patients and controls. Incubation of PBMNC from patients with acute brucellar infection with recombinant interleukin-2, but not with interferon-gamma, can correct this impaired cytotoxic activity. In treated patients, there was a significant enhancement (P < .05) and normalization of the previously defective NK cell activity. It is concluded that acute brucellar infection is associated with a deficient cytotoxic activity of NK cells that can be overcome by in vitro incubation with interleukin-2 and that reverts to normal after antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445973     DOI: 10.1093/clind/15.5.764

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

1.  Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages.

Authors:  V Jubier-Maurin; R A Boigegrain; A Cloeckaert; A Gross; M T Alvarez-Martinez; A Terraza; J Liautard; S Köhler; B Rouot; J Dornand; J P Liautard
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Defective reactive oxygen metabolite generation by macrophages from acute brucellosis patients.

Authors:  M Rodriguez-Zapata; E Reyes; L Sanchez; A Espinosa; J Solera; M Alvarez-Mon
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553

Review 3.  Alpha interferon as an immunomodulator in the treatment of patients with tumors.

Authors:  M Alvarez-Mon; O J Salmerón; L Manzano; M Rodríguez-Zapata; E Reyes; L M Vaquer; J Carballido
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

4.  Diminished T lymphocyte proliferative response to polyclonal mitogens in acute brucellosis patients.

Authors:  M Rodriguez-Zapata; M Alvarez-Mon; I Salmeron; A Prieto; L Manzano; O J Salmeron; J Carballido
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

5.  Human brucellosis is characterized by an intense Th1 profile associated with a defective monocyte function.

Authors:  Manuel Rodríguez-Zapata; Marlene J Matías; Alfredo Prieto; Marco A Jonde; Jorge Monserrat; Lorenzo Sánchez; Eduardo Reyes; Antonio De la Hera; Melchor Alvarez-Mon
Journal:  Infect Immun       Date:  2010-04-19       Impact factor: 3.441

6.  Comparative analysis of the early transcriptome of Brucella abortus--infected monocyte-derived macrophages from cattle naturally resistant or susceptible to brucellosis.

Authors:  C A Rossetti; C L Galindo; R E Everts; H A Lewin; H R Garner; L G Adams
Journal:  Res Vet Sci       Date:  2010-10-06       Impact factor: 2.534

7.  Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages.

Authors:  A Gross; S Spiesser; A Terraza; B Rouot; E Caron; J Dornand
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

8.  Lack of a role for natural killer cells in early control of Brucella abortus 2308 infections in mice.

Authors:  D M Fernandes; R Benson; C L Baldwin
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 9.  Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans.

Authors:  Jinkyung Ko; Gary A Splitter
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

10.  Impairment of intramacrophagic Brucella suis multiplication by human natural killer cells through a contact-dependent mechanism.

Authors:  Jacques Dornand; Virginie Lafont; Jane Oliaro; Annie Terraza; Elsa Castaneda-Roldan; Jean-Pierre Liautard
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.